Loading chat...

MO HB1881

Bill

Official Source

Status

Introduced

1/7/2026

Primary Sponsor

Bill Allen

Click for details

Origin

House of Representatives

2026 Regular Session

AI Summary

  • Xylazine is added to Missouri's Schedule III controlled substances under section 195.017, RSMo
  • Exemptions allow xylazine use when dispensed, prescribed, or administered to animals under FDA-approved drugs (21 U.S.C. Section 360b)
  • Additional exemptions permit xylazine as an active pharmaceutical ingredient for manufacturing approved animal drugs or those with investigation use exemptions
  • Licensed pharmacists and veterinarians may use xylazine bulk chemicals for pharmaceutical compounding
  • Federal law references for exemptions cite January 1, 2026 as the applicable date

Legislative Description

Adds xylazine to the list of Schedule III controlled substances

Last Action

Referred: Rules - Administrative(H)

3/4/2026

Committee Referrals

Rules - Administrative3/4/2026
Health and Mental Health1/8/2026

Full Bill Text

No bill text available